Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:26 PM
Study NCT ID:
NCT03190278
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2017-06-14
Brief Title:
Study Evaluating Safety and Efficacy of UCART123v12 in Patients With RelapsedRefractory Acute Myeloid Leukemia
Sponsor:
Cellectis SA
Organization:
Cellectis SA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-14
First Submit QC Date:
June 15 2017
Study First Post Date:
2017-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-31
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL